Autopsy report · NCT02277132

The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Results of interim analysis”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months before it started.
Ran for about 3 years 6 months before it stopped.
216 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2, Phase 3
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sponsor type: University, hospital or other
Conditions: Fetal Growth Restriction
Interventions: Sildenafil; Placebo
Participants: 216
Sites: 10
Countries: Netherlands

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.